Literature DB >> 19421057

Cerebellar ataxias.

Mario Manto1, Daniele Marmolino.   

Abstract

PURPOSE OF REVIEW: The term 'cerebellar ataxias' encompasses the various cerebellar disorders encountered during daily practice. Patients exhibit a cerebellar syndrome and can also present with pigmentary retinopathy, extrapyramidal movement disorders, pyramidal signs, cortical symptoms (seizures, cognitive impairment/behavioural symptoms), and peripheral neuropathy. The clinical diagnosis of subtypes of ataxias is complicated by the salient overlap of the phenotypes between genetic subtypes. The identification of the causative mutations of many hereditary ataxias and the development of relevant animal models bring hope for effective therapies in neurodegenerative ataxias. RECENT
FINDINGS: We describe the current classification of cerebellar ataxias and underline the recent discoveries in molecular pathogenesis. Cerebellar disorders can be divided into sporadic forms and inherited diseases. Inherited ataxias include autosomal recessive cerebellar ataxias, autosomal dominant cerebellar ataxias/spinocerebellar ataxia) and episodic ataxias, and X-linked ataxias. From a motor control point of view, the leading theories of ataxia are based on neural representations or 'internal models' to emulate fundamental natural processes such as body motion.
SUMMARY: Recent molecular advances have direct implications for research and daily practice. We provide a framework for the diagnosis of ataxias. For the first time, the therapeutic agents under investigation are targeted to deleterious pathways.

Entities:  

Mesh:

Year:  2009        PMID: 19421057     DOI: 10.1097/WCO.0b013e32832b9897

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  65 in total

1.  Suppression of calbindin-D28k expression exacerbates SCA1 phenotype in a disease mouse model.

Authors:  Parminder J S Vig; Jinrong Wei; Qingmei Shao; Maripar E Lopez; Rebecca Halperin; Jill Gerber
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

2.  Gene transfer to the cerebellum.

Authors:  Jean-Pierre Louboutin; Beverly A S Reyes; Elisabeth J Van Bockstaele; David S Strayer
Journal:  Cerebellum       Date:  2010-12       Impact factor: 3.847

3.  Exome sequencing reveals a homozygous SYT14 mutation in adult-onset, autosomal-recessive spinocerebellar ataxia with psychomotor retardation.

Authors:  Hiroshi Doi; Kunihiro Yoshida; Takao Yasuda; Mitsunori Fukuda; Yoko Fukuda; Hiroshi Morita; Shu-ichi Ikeda; Rumiko Kato; Yoshinori Tsurusaki; Noriko Miyake; Hirotomo Saitsu; Haruya Sakai; Satoko Miyatake; Masaaki Shiina; Nobuyuki Nukina; Shigeru Koyano; Shoji Tsuji; Yoshiyuki Kuroiwa; Naomichi Matsumoto
Journal:  Am J Hum Genet       Date:  2011-08-12       Impact factor: 11.025

Review 4.  Emerging therapies in Friedreich's ataxia.

Authors:  Tanya V Aranca; Tracy M Jones; Jessica D Shaw; Joseph S Staffetti; Tetsuo Ashizawa; Sheng-Han Kuo; Brent L Fogel; George R Wilmot; Susan L Perlman; Chiadi U Onyike; Sarah H Ying; Theresa A Zesiewicz
Journal:  Neurodegener Dis Manag       Date:  2016

5.  Genetics of ataxias: hereditary forms.

Authors:  N Tirada; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-12-26       Impact factor: 3.825

6.  Utilization of genetic testing prior to subspecialist referral for cerebellar ataxia.

Authors:  Brent L Fogel; Barbara G Vickrey; Jenny Walton-Wetzel; Eli Lieber; Carole H Browner
Journal:  Genet Test Mol Biomarkers       Date:  2013-06-01

7.  Treatment of Spinocerebellar Ataxia With Mesenchymal Stem Cells: A Phase I/IIa Clinical Study.

Authors:  Yun-An Tsai; Ren-Shyan Liu; Jiing-Feng Lirng; Bang-Hung Yang; Chin-Hao Chang; Yi-Chen Wang; Yu-Shan Wu; Jennifer Hui-Chun Ho; Oscar K Lee; Bing-Wen Soong
Journal:  Cell Transplant       Date:  2017-02-14       Impact factor: 4.064

8.  Lgr4 protein deficiency induces ataxia-like phenotype in mice and impairs long term depression at cerebellar parallel fiber-Purkinje cell synapses.

Authors:  Xin Guan; Yanhong Duan; Qingwen Zeng; Hongjie Pan; Yu Qian; Dali Li; Xiaohua Cao; Mingyao Liu
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 9.  Ataxia.

Authors:  Umar Akbar; Tetsuo Ashizawa
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

10.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.